Modulating protein-protein interactions with small molecules: The importance of binding hotspots

Journal of Molecular Biology

Volumn 415, Issue 2, 2012, Pages 443-453

  Thangudu, Ratna Rajesh ^a   Bryant, Stephen H ^a   Panchenko, Anna R ^a   Madej, Thomas ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

drug development hotspots; molecular interactions; protein structures; protein protein interactions

Indexed keywords

PEPTIDE;

ARTICLE; BINDING SITE; DRUG DESIGN; LARGE SCALE PRODUCTION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 84855812283     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.12.026     Document Type: Article

References (58)

1. Schuster-Bockler B., and Bateman A. Protein interactions in human genetic diseases Genome Biol. 9 2008 R9
2. Teng S., Madej T., Panchenko A., and Alexov E. Modeling effects of human single nucleotide polymorphisms on protein-protein interactions Biophys. J. 96 2009 2178 2188
3. Fletcher S., and Hamilton A.D. Protein-protein interaction inhibitors: small molecules from screening techniques Curr. Top. Med. Chem. 7 2007 922 927 (Pubitemid 47040520)
4. Pagliaro L., Felding J., Audouze K., Nielsen S.J., Terry R.B., Krog-Jensen C., and Butcher S. Emerging classes of protein-protein interaction inhibitors and new tools for their development Curr. Opin. Chem. Biol. 8 2004 442 449 (Pubitemid 38993738)
5. Fry D.C. Protein-protein interactions as targets for small molecule drug discovery Biopolymers 84 2006 535 552 (Pubitemid 44935254)
6. Fry D.C. Drug-like inhibitors of protein-protein interactions: a structural examination of effective protein mimicry Curr. Protein Pept. Sci. 9 2008 240 247 (Pubitemid 351997840)
7. Keskin O., Gursoy A., Ma B., and Nussinov R. Principles of protein-protein interactions: what are the preferred ways for proteins to interact? Chem. Rev. 108 2008 1225 1244 (Pubitemid 351638814)
8. Whitty A., and Kumaravel G. Between a rock and a hard place? Nat. Chem. Biol. 2 2006 112 118 (Pubitemid 44323856)
9. Reynes C., Host H., Camproux A.C., Laconde G., Leroux F., and Mazars A. Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods PLoS Comput. Biol. 6 2010 e1000695
10. Asada S., Choi Y., and Uesugi M. A gene-expression inhibitor that targets an α-helix-mediated protein interaction J. Am. Chem. Soc. 125 2003 4992 4993 (Pubitemid 36520425)
11. Bruncko M., Oost T.K., Belli B.A., Ding H., Joseph M.K., and Kunzer A. Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL J. Med. Chem. 50 2007 641 662 (Pubitemid 46332978)
12. Charpentier T.H., Wilder P.T., Liriano M.A., Varney K.M., Zhong S., and Coop A. Small molecules bound to unique sites in the target protein binding cleft of calcium-bound S100B as characterized by nuclear magnetic resonance and X-ray crystallography Biochemistry 48 2009 6202 6212
13. Daelemans D. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export Proc. Natl Acad. Sci. USA 99 2002 14440 14445 (Pubitemid 35257690)
14. Lepourcelet M., Chen Y.N.P., France D.S., Wang H., Crews P., and Petersen F. Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex Cancer Cell 5 2004 91 102 (Pubitemid 38121599)
15. Murray J.K., and Gellman S.H. Targeting protein-protein interactions: lessons from p53/MDM2 Biopolymers 88 2007 657 686 (Pubitemid 47556148)
16. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., and Belli B.A. An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 435 2005 677 681 (Pubitemid 40825512)
17. Oost T.K., Sun C., Armstrong R.C., Al-Assaad A.S., Betz S.F., and Deckwerth T.L. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer J. Med. Chem. 47 2004 4417 4426 (Pubitemid 39096830)
18. Sutherland A.G., Alvarez J., Ding W., Foreman K.W., Kenny C.H., and Labthavikul P. Structure-based design of carboxybiphenylindole inhibitors of the ZipA-FtsZ interaction Org. Biomol. Chem. 1 2003 4138
19. Tilley J.W., Chen L., Fry D.C., Emerson S.D., Powers G.D., and Biondi D. Identification of a small molecule inhibitor of the IL-2/IL-2Rα receptor interaction which binds to IL-2 J. Am. Chem. Soc. 119 1997 7589 7590 (Pubitemid 27355129)
20. Tsao D.H.H., Sutherland A.G., Jennings L.D., Li Y., Rush Iii T.S., and Alvarez J.C. Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design Bioorg. Med. Chem. 14 2006 7953 7961 (Pubitemid 44584704)
21. Wang Y. Crystal structure of the E2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitor J. Biol. Chem. 279 2003 6976 6985
22. Volkov A.N., Worrall J.A., Holtzmann E., and Ubbink M. Solution structure and dynamics of the complex between cytochrome c and cytochrome c peroxidase determined by paramagnetic NMR Proc. Natl Acad. Sci. USA 103 2006 18945 18950 (Pubitemid 350002808)
23. Eyrisch S., and Helms V. Transient pockets on protein surfaces involved in protein-protein interaction J. Med. Chem. 50 2007 3457 3464 (Pubitemid 47195455)
24. Fong J.H., Shoemaker B.A., Garbuzynskiy S.O., Lobanov M.Y., Galzitskaya O.V., and Panchenko A.R. Intrinsic disorder in protein interactions: insights from a comprehensive structural analysis PLoS Comput. Biol. 5 2009 e1000316
25. Arkin M.R., and Wells J.A. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream Nat. Rev., Drug Discov. 3 2004 301 317 (Pubitemid 38499758)
26. Higueruelo A.P., Schreyer A., Bickerton G.R., Pitt W.R., Groom C.R., and Blundell T.L. Atomic interactions and profile of small molecules disrupting protein-protein interfaces: the TIMBAL database Chem. Biol. Drug Des. 74 2009 457 467
27. Morell M., Aviles F.X., and Ventura S. Detecting and interfering protein interactions: towards the control of biochemical pathways Curr. Med. Chem. 16 2009 362 379
28. Toogood P.L. Inhibition of protein-protein association by small molecules: approaches and progress J. Med. Chem. 45 2002 1543 1558 (Pubitemid 34293520)
29. Wells J.A., and McClendon C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces Nature 450 2007 1001 1009 (Pubitemid 350273630)
30. Assi S.A., Tanaka T., Rabbitts T.H., and Fernandez-Fuentes N. PCRPi: Presaging Critical Residues in Protein interfaces, a new computational tool to chart hot spots in protein interfaces Nucleic Acids Res. 38 2010 e86
31. Arkin M.R., Randal M., DeLano W.L., Hyde J., Luong T.N., and Oslob J.D. Binding of small molecules to an adaptive protein-protein interface Proc. Natl Acad. Sci. USA 100 2003 1603 1608 (Pubitemid 36254494)
32. Cheng A.C., Coleman R.G., Smyth K.T., Cao Q., Soulard P., and Caffrey D.R. Structure-based maximal affinity model predicts small-molecule druggability Nat. Biotechnol. 25 2007 71 75 (Pubitemid 46087905)
33. Bourgeas R., Basse M.J., Morelli X., and Roche P. Atomic analysis of protein-protein interfaces with known inhibitors: the 2P2I database PLoS One 5 2010 e9598
34. Davis F.P., and Sali A. The overlap of small molecule and protein binding sites within families of protein structures PLoS Comput. Biol. 6 2010 e1000668
35. Davis F.P. Proteome-wide prediction of overlapping small molecule and protein binding sites using structure Mol. Biosyst. 7 2011 545 557
36. Krissinel E., and Henrick K. Inference of macromolecular assemblies from crystalline state J. Mol. Biol. 372 2007 774 797 (Pubitemid 47321791)
37. Xu Q., and Dunbrack R.L. Jr The protein common interface database (ProtCID)-a comprehensive database of interactions of homologous proteins in multiple crystal forms Nucleic Acids Res. 39 2011 D761 D770
38. Schnoes A.M., Brown S.D., Dodevski I., and Babbitt P.C. Annotation error in public databases: misannotation of molecular function in enzyme superfamilies PLoS Comput. Biol. 5 2009 e1000605
39. Shoemaker B.A., Zhang D., Thangudu R.R., Tyagi M., Fong J.H., and Marchler-Bauer A. Inferred Biomolecular Interaction Server-a web server to analyze and predict protein interacting partners and binding sites Nucleic Acids Res. 38 2010 D518 D524
40. Thangudu R.R., Tyagi M., Shoemaker B.A., Bryant S.H., Panchenko A.R., and Madej T. Knowledge-based annotation of small molecule binding sites in proteins BMC Bioinformatics 11 2010 365
41. Berman H., Henrick K., Nakamura H., and Markley J.L. The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data Nucleic Acids Res. 35 2007 D301 D303
42. Knox C., Law V., Jewison T., Liu P., Ly S., and Frolkis A. DrugBank 3.0: a comprehensive resource for "omics" research on drugs Nucleic Acids Res. 39 2011 D1035 D1041
43. Ofran Y., and Rost B. Protein-protein interaction hotspots carved into sequences PLoS Comput. Biol. 3 2007 e119
44. Bashton M., Nobeli I., and Thornton J.M. PROCOGNATE: a cognate ligand domain mapping for enzymes Nucleic Acids Res. 36 2008 D618 D622
45. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., and Cherry J.M. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat. Genet. 25 2000 25 29 (Pubitemid 30257031)
46. Bauer S., Grossmann S., Vingron M., and Robinson P.N. Ontologizer 2.0-a multifunctional tool for GO term enrichment analysis and data exploration Bioinformatics 24 2008 1650 1651 (Pubitemid 351966169)
47. Grossmann S., Bauer S., Robinson P.N., and Vingron M. Improved detection of overrepresentation of Gene-Ontology annotations with parent-child analysis Bioinformatics 23 2007 3024 3031 (Pubitemid 350162867)
48. Bairoch A. The ENZYME database in 2000 Nucleic Acids Res. 28 2000 304 305 (Pubitemid 30047788)
49. Wurtele M., Jelich-Ottmann C., Wittinghofer A., and Oecking C. Structural view of a fungal toxin acting on a 14-3-3 regulatory complex EMBO J. 22 2003 987 994 (Pubitemid 36313583)
50. Rose R., Erdmann S., Bovens S., Wolf A., Rose M., and Hennig S. Identification and structure of small-molecule stabilizers of 14-3-3 protein-protein interactions Angew. Chem., Int. Ed. Engl. 49 2010 4129 4132
51. Choi J., Chen J., Schreiber S.L., and Clardy J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP Science 273 1996 239 242 (Pubitemid 26285890)
52. Huse M., Chen Y.G., Massague J., and Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12 Cell 96 1999 425 436 (Pubitemid 29077596)
53. Peterson F.C., Penkert R.R., Volkman B.F., and Prehoda K.E. Cdc42 regulates the Par-6 PDZ domain through an allosteric CRIB-PDZ transition Mol. Cell 13 2004 665 676 (Pubitemid 38368124)
54. Antonyuk S., Strange R.W., and Hasnain S.S. Structural discovery of small molecule binding sites in Cu-Zn human superoxide dismutase familial amyotrophic lateral sclerosis mutants provides insights for lead optimization J. Med. Chem. 53 2010 1402 1406
55. Chen J., Anderson J.B., DeWeese-Scott C., Fedorova N.D., Geer L.Y., and He S. MMDB: Entrez's 3D structure database Nucleic Acids Res. 31 2003 474 477
56. Marchler-Bauer A., Anderson J.B., Chitsaz F., Derbyshire M.K., DeWeese-Scott C., and Fong J.H. CDD: specific functional annotation with the Conserved Domain Database Nucleic Acids Res. 37 2009 D205 D210
57. Gibrat J.F., Madej T., and Bryant S.H. Surprising similarities in structure comparison Curr. Opin. Struct. Biol. 6 1996 377 385 (Pubitemid 26197439)
58. Wang Y., Xiao J., Suzek T.O., Zhang J., Wang J., and Bryant S.H. PubChem: a public information system for analyzing bioactivities of small molecules Nucleic Acids Res. 37 2009 W623 W633